PODD Drug Delivery Conference Announces 2025 Keynotes
The Conference Forum announces the 15th annual PODD Drug Delivery Conference's 2025 keynotes
NEW YORK, June 18, 2025 /PRNewswire/ -- Today, PODD: Partnership Opportunities in Drug Delivery conference announced the keynotes for its 15th annual conference which takes place on October 27-28 at the Westin Copley Place in Boston, MA.
"In presenting a strategic-level program for R&D scientists and business development professionals, the PODD Conference is committed to securing keynotes who demonstrate excellence in science," said Andrew Goldstein, Senior Conference Producer for the PODD Conference.
The PODD 2025 keynotes include:
MIT's Dr Robert Langer, a pioneer in the research and development of drug delivery technology, will return as the Annual Keynote to discuss the state of innovation in the drug delivery industry.
Dr Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor who drove the development of GLP-1 drugs for obesity will present on the liraglutide and semaglutide story, her approach to scientific development and where drug delivery intersects with her R&D work.
Patient Keynote Jimi Olaghere will share his journey as a patient with sickle cell disease before and after receiving CASGEVY, a CRISPR-based therapy, and his mission to make these therapies more accessible for patients globally.
Dr Mansoor Amiji, University Distinguished Professor, Northwestern University, will join the PODD Conference as the Endogenous Delivery Zeitgeist. Dr Amiji will present on endogenous targeted delivery strategies to overcome biological barriers and improve efficacy and safety.
The PODD speaking faculty includes over 100 executives from both the drug development and delivery industries with over 125 session choices including a full afternoon of drug delivery presentations from established to start-up companies.
To learn more about the event, visit PODDConference.com
About the PODD: Partnership Opportunities in Drug Delivery ConferencePharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals, and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.
About the Conference ForumThe Conference Forum is a life science industry research firm that develops conferences, podcasts, newsletters and webinars primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, promoting the exchange of ideas and solutions among peers, and providing high-quality networking.
Learn more about the Conference Forum at theconferenceforum.org.
For media inquiries, contact:Bre Bugbee-Barrettbre@tcfllc.org
View original content:https://www.prnewswire.com/news-releases/podd-drug-delivery-conference-announces-2025-keynotes-302484499.html
SOURCE Partnership Opportunities in Drug Delivery (PODD)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
DraftKings (DKNG) Imposes Fee to Offset Illinois' New Tax, Jefferies Maintains a Buy
DraftKings Inc. (NASDAQ:DKNG) is one of the 10 best growth stocks to buy according to billionaires. On June 10, Jefferies analyst David Katz released a note discussing the impact of the Illinois legislature's approval of a new betting transaction tax on all in-state wagers announced in the first week of June. As a result of the higher tax, operators are expected to adjust their fees accordingly. The new transaction tax, effective from July 1, requires operators to be charged $0.25 for each bet up to 20 million bets and $0.50 for each additional bet thereafter. On June 10, Flutter Entertainment plc (NYSE:FLTR), another player in the space, announced a $0.50 fee for each bet made on its FanDuel platform, effective September 1, to offset the added cost. According to Jefferies analyst David Katz, this move is likely to set a precedent across the industry. Following the development, Katz believed that DraftKings is likely to adopt a similar surcharge model, given its practicality in directly addressing the tax burden. While such a fee could be passed through to consumers, the analyst views the development as moderately positive for the stock. He maintained a Buy rating on DraftKings, with a $60 price target, reflecting continued confidence in the company's ability to navigate evolving regulatory frameworks. Notably, two days after the analyst's note, on June 12, DraftKings also announced that it would implement a $0.50 transaction fee on all mobile and online bets placed in Illinois, effective September 1. While the company CEO, Jason Robins, shared his disappointment over the tripling of the company's tax rate in the state over the past two years, he offered to remove the fee immediately if the new legislation is repealed. DraftKings Inc. is a Boston, Massachusetts-based gambling company that offers sportsbook and daily fantasy sports (DFS) services. While we acknowledge the potential of DKNG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Axios
34 minutes ago
- Axios
Exclusive: Maven AGI raises $50M Series B
Maven AGI, which builds enterprise AI agents for customer support, raised a $50 million Series B led by Dell Technologies Capital, co-founder and CEO Jonathan Corbin tells Axios Pro. Why it matters: AI agents are all the rage right now, especially in areas stretched thin, like customer service. State of play: Several startups have raised money for AI customer service agents, including Parloa's massive $120 million Series C last month. How it works: Maven's agents are designed specifically for large enterprises, integrating with the myriad systems used by big companies and cleaning up old data sets. Maven's autonomous agents resolve up to 93% of customer questions, Corbin said. The company's AI agents can also be used internally by companies to support workflows. Zoom in: The round also included participation from Cisco Investments, SE Ventures, Pathlight Ventures, Lux Capital, M13 and E14. Founded in 2023, the Boston-based company has now raised a total of $78 million. By the numbers: In less than 12 months, Maven has scaled from zero to $7 million in annual recurring revenue, per the company. It has signed up 30 enterprise customers in its first year, including Tripadvisor, Clio and Paris Hilton's Parivie beauty line. What they're saying:"Maven just stands out in this very crowded landscape," Elana Lian, partner at Dell, says about investing in the very competitive agentic AI customer service sector.
News24
37 minutes ago
- News24
Elon Musk's X Corp sues to block New York social media transparency law
• Elon Musk's X Corp has filed a federal lawsuit against a New York state law 'Stop Hiding Hate Act' that requires social media companies to submit semi-annual reports on how they moderate hate speech and disinformation. • X argues the law violates the First Amendment by forcing platforms to disclose sensitive moderation practices. • The law targets companies with over $100 million in annual revenue, imposes $15 000 daily fines for violations. Elon Musk's X Corp has filed a lawsuit challenging a New York state law that requires social media companies to report how they moderate hate speech and disinformation. The complaint, filed in a federal court in Manhattan, seeks to halt the law, which X argues violates the First Amendment by forcing platforms to disclose sensitive information about their content moderation practices. "Today, @X filed a First Amendment lawsuit against a New York law, NY S895B," X's Global Government Affairs team posted Tuesday, adding that it had successfully challenged a similar law in California. "X is the only platform fighting for its users by challenging the law, and we are confident we will prevail in this case as well," the company said. The New York law requires social media companies with more than $100 million in annual revenue to submit semi-annual reports detailing how they define and moderate hate speech, racism, extremism, disinformation and harassment. Companies face fines of $15 000 per day for violations, which can be sought by the attorney general's office. X says the law is "an impermissible attempt by the State to inject itself into the content-moderation editorial process" and seeks to pressure platforms into restricting constitutionally protected speech. The lawsuit comes after X successfully challenged a nearly identical California law last year, according to the filing. New York's law is "a carbon copy" of the California provisions that were struck down, the filing adds. X claims New York lawmakers refused to discuss changes to the bill after the California ruling, with sponsors saying they declined to meet because of content on X promoted by owner Musk that "threatens the foundations of our democracy." READ | Musk's X sues to block California anti-hate speech law The company argues this indicated "viewpoint discriminatory motives" behind the law's passage. Senator Brad Hoylman-Sigal and Assembly member Grace Lee - who introduced the law - said in a statement that their act "does not infringe upon the First Amendment rights of social media companies, nor does it conflict with federal law". "Instead, the Stop Hiding Hate Act requires narrowly tailored disclosures by social media companies to allow consumers to better decide which social media platforms they utilise," they added. "The fact that Elon Musk would go to these lengths to avoid disclosing straightforward information to New Yorkers as required by our statute illustrates exactly why we need the Stop Hiding Hate Act."
